SHL Telemedicine (XSWX:SHLTN) Beneish M-Score: -3.22 (As of Jun. 26, 2026)


XSWX:SHLTN SHL Telemedicine Ltd XSWX:SHLTN
51 GF Score
Price CHF0.91
GF Value CHF2.62
Valuation Possible Value Trap
! 3 Warning Signs
View Full Analysis

What is SHL Telemedicine Beneish M-Score?

SHL Telemedicine XSWX:SHLTN 51 Beneish M-Score is -3.22 as of Jun. 26, 2026. GuruFocus rates XSWX:SHLTN with a GF Score™ of 51/100 and a GF Value™ of CHF2.62 (Possible Value Trap). The stock has 3 warning signs investors should review. Among 633 Healthcare Providers & Services companies, SHL Telemedicine ranks better than 84.68% on this metric.

The zones of discrimination for M-Score is as such:

An M-Score of equal or less than -1.78 suggests that the company is unlikely to be a manipulator.
An M-Score of greater than -1.78 signals that the company is likely to be a manipulator.

Good Sign:

Beneish M-Score -3.22 no higher than -1.78, which implies that the company is unlikely to be a manipulator.

The historical rank and industry rank for SHL Telemedicine's Beneish M-Score or its related term are showing as below:

XSWX:SHLTN' s Beneish M-Score Range Over the Past 10 Years
Min: -3.31   Med: -2.96   Max: -1.9
Current: -3.22

During the past 13 years, the highest Beneish M-Score of SHL Telemedicine was -1.90. The lowest was -3.31. And the median was -2.96.


SHL Telemedicine Beneish M-Score Historical Data

* Premium members only.

The historical data trend for SHL Telemedicine's Beneish M-Score can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

SHL Telemedicine Beneish M-Score Chart

SHL Telemedicine Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Beneish M-Score
Get a 7-Day Free Trial Premium Member Only Premium Member Only -1.90 -2.74 -2.69 -3.20 -3.22

SHL Telemedicine Semi-Annual Data
Jun16 Dec16 Jun17 Dec17 Jun18 Dec18 Jun19 Dec19 Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23 Jun24 Dec24 Jun25 Dec25
Beneish M-Score Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -2.69 0.00 -3.20 0.00 -3.22

XSWX:SHLTN vs VEEV, BTSG, TEM: Beneish M-Score Comparison

For the Health Information Services subindustry, SHL Telemedicine's Beneish M-Score, along with its competitors' market caps and Beneish M-Score data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


SHL Telemedicine Beneish M-Score vs Healthcare Providers & Services Industry

For the Healthcare Providers & Services industry and Healthcare sector, SHL Telemedicine's Beneish M-Score distribution charts can be found below:

* The bar in red indicates where SHL Telemedicine's Beneish M-Score falls into.


XSWX:SHLTN
51GF Score
SHL Telemedicine Ltd XSWX:SHLTN
Beneish M-Score is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

SHL Telemedicine Beneish M-Score Calculation

The M-score was created by Professor Messod Beneish. Instead of measuring the bankruptcy risk (Altman Z-Score) or business trend (Piotroski F-Score), M-score can be used to detect the risk of earnings manipulation. This is the original research paper on M-score.

The M-Score Variables:

The M-score of SHL Telemedicine for today is based on a combination of the following eight different indices:

M=-4.84+0.92 * DSRI+0.528 * GMI+0.404 * AQI+0.892 * SGI+0.115 * DEPI
=-4.84+0.92 * 1.1433+0.528 * 0.967+0.404 * 0.8934+0.892 * 0.9239+0.115 * 0.8832
-0.172 * SGAI+4.679 * TATA-0.327 * LVGI
-0.172 * 0.9876+4.679 * -0.160231-0.327 * 0.9431
=-3.22

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

This Year (Dec25) TTM:Last Year (Dec24) TTM:
Total Receivables was CHF7.15 Mil.
Revenue was CHF46.77 Mil.
Gross Profit was CHF21.97 Mil.
Total Current Assets was CHF28.88 Mil.
Total Assets was CHF67.43 Mil.
Property, Plant and Equipment(Net PPE) was CHF6.85 Mil.
Depreciation, Depletion and Amortization(DDA) was CHF5.97 Mil.
Selling, General, & Admin. Expense(SGA) was CHF8.74 Mil.
Total Current Liabilities was CHF23.13 Mil.
Long-Term Debt & Capital Lease Obligation was CHF7.05 Mil.
Net Income was CHF-12.25 Mil.
Gross Profit was CHF0.00 Mil.
Cash Flow from Operations was CHF-1.45 Mil.
Total Receivables was CHF6.77 Mil.
Revenue was CHF50.62 Mil.
Gross Profit was CHF23.00 Mil.
Total Current Assets was CHF24.49 Mil.
Total Assets was CHF72.01 Mil.
Property, Plant and Equipment(Net PPE) was CHF9.62 Mil.
Depreciation, Depletion and Amortization(DDA) was CHF6.72 Mil.
Selling, General, & Admin. Expense(SGA) was CHF9.58 Mil.
Total Current Liabilities was CHF23.66 Mil.
Long-Term Debt & Capital Lease Obligation was CHF10.50 Mil.




1. DSRI = Days Sales in Receivables Index

Measured as the ratio of Revenue in Total Receivables in year t to year t-1.

A large increase in DSR could be indicative of revenue inflation.

DSRI=(Receivables_t / Revenue_t) / (Receivables_t-1 / Revenue_t-1)
=(7.147 / 46.773) / (6.766 / 50.624)
=0.152802 / 0.133652
=1.1433

2. GMI = Gross Margin Index

Measured as the ratio of gross margin in year t-1 to gross margin in year t.

Gross margin has deteriorated when this index is above 1. A firm with poorer prospects is more likely to manipulate earnings.

GMI=GrossMargin_t-1 / GrossMargin_t
=(GrossProfit_t-1 / Revenue_t-1) / (GrossProfit_t / Revenue_t)
=(22.997 / 50.624) / (21.972 / 46.773)
=0.454271 / 0.469758
=0.967

3. AQI = Asset Quality Index

AQI is the ratio of asset quality in year t to year t-1.

Asset quality is measured as the ratio of non-current assets other than Property, Plant and Equipment to Total Assets.

AQI=(1 - (CurrentAssets_t + PPE_t) / TotalAssets_t) / (1 - (CurrentAssets_t-1 + PPE_t-1) / TotalAssets_t-1)
=(1 - (28.884 + 6.845) / 67.434) / (1 - (24.494 + 9.619) / 72.005)
=0.470163 / 0.526241
=0.8934

4. SGI = Sales Growth Index

Ratio of Revenue in year t to sales in year t-1.

Sales growth is not itself a measure of manipulation. However, growth companies are likely to find themselves under pressure to manipulate in order to keep up appearances.

SGI=Sales_t / Sales_t-1
=Revenue_t / Revenue_t-1
=46.773 / 50.624
=0.9239

5. DEPI = Depreciation Index

Measured as the ratio of the rate of Depreciation, Depletion and Amortization in year t-1 to the corresponding rate in year t.

DEPI greater than 1 indicates that assets are being depreciated at a slower rate. This suggests that the firm might be revising useful asset life assumptions upwards, or adopting a new method that is income friendly.

DEPI=(Depreciation_t-1 / (Depreciaton_t-1 + PPE_t-1)) / (Depreciation_t / (Depreciaton_t + PPE_t))
=(6.724 / (6.724 + 9.619)) / (5.969 / (5.969 + 6.845))
=0.41143 / 0.465819
=0.8832

Note: If the Depreciation, Depletion and Amortization data is not available, we assume that the depreciation rate is constant and set the Depreciation Index to 1.

6. SGAI = Sales, General and Administrative expenses Index

The ratio of Selling, General, & Admin. Expense(SGA) to Sales in year t relative to year t-1.

SGA expenses index > 1 means that the company is becoming less efficient in generate sales.

SGAI=(SGA_t / Sales_t) / (SGA_t-1 /Sales_t-1)
=(8.738 / 46.773) / (9.576 / 50.624)
=0.186817 / 0.189159
=0.9876

7. LVGI = Leverage Index

The ratio of total debt to Total Assets in year t relative to yeat t-1.

An LVGI > 1 indicates an increase in leverage

LVGI=((LTD_t + CurrentLiabilities_t) / TotalAssets_t) / ((LTD_t-1 + CurrentLiabilities_t-1) / TotalAssets_t-1)
=((7.051 + 23.127) / 67.434) / ((10.504 + 23.664) / 72.005)
=0.447519 / 0.474523
=0.9431

8. TATA = Total Accruals to Total Assets

Total accruals calculated as the change in working capital accounts other than cash less depreciation.

TATA=(IncomefromContinuingOperations_t - CashFlowsfromOperations_t) / TotalAssets_t
=(NetIncome_t - NonOperatingIncome_t - CashFlowsfromOperations_t) / TotalAssets_t
=(-12.254 - 0 - -1.449) / 67.434
=-0.160231

An M-Score of equal or less than -1.78 suggests that the company is unlikely to be a manipulator. An M-Score of greater than -1.78 signals that the company is likely to be a manipulator.

SHL Telemedicine has a M-score of -3.22 suggests that the company is unlikely to be a manipulator.

Frequently Asked Questions Learn more about Beneish M-Score →
What does a Beneish M-Score of -3.22 mean?
SHL Telemedicine (XSWX:SHLTN) has a Beneish M-Score of -3.22 as of Jun. 26, 2026. The Beneish M-score measures the likelihood of earnings manipulation. View historical data on SHL Telemedicine and its competitors. According to the industry distribution chart, SHL Telemedicine ranks #97 out of 633 companies in the Healthcare Providers & Services industry, placing it in the top 15.3%.
Is SHL Telemedicine's Beneish M-Score too high?
SHL Telemedicine's current Beneish M-Score is -3.22. Based on the distribution chart, SHL Telemedicine ranks #97 out of 633 companies in the Healthcare Providers & Services industry, which is in the top quartile — a strong position relative to peers. Overall, SHL Telemedicine has a GF Score™ of 51/100 and is considered Possible Value Trap, reflecting its overall financial health beyond just this single metric.
How does SHL Telemedicine's Beneish M-Score compare to VEEV and BTSG?
According to the Healthcare Providers & Services industry distribution chart, SHL Telemedicine ranks #97 out of 633 companies for Beneish M-Score. This places SHL Telemedicine in the top 15% of its industry — outperforming the majority of peers. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Beneish M-Score for a Healthcare Providers & Services company?
A good Beneish M-Score depends on the Healthcare Providers & Services industry context. However, Beneish M-Score should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Beneish M-Score mean?
A high Beneish M-Score can signal that a stock is expensive relative to its fundamentals. The Beneish M-score measures the likelihood of earnings manipulation. View historical data on SHL Telemedicine and its competitors. SHL Telemedicine's current Beneish M-Score is -3.22. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is SHL Telemedicine stock overvalued right now?
Based on GuruFocus' analysis, SHL Telemedicine (XSWX:SHLTN) is currently considered Possible Value Trap. The stock's GF Value™ is CHF2.62, compared to a current price of CHF0.91 — trading 65.3% below its estimated fair value. The current Beneish M-Score is -3.22. SHL Telemedicine's overall GF Score™ is 51/100 with 3 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Beneish M-Score calculated?
Beneish M-Score is calculated from a company's financial statements. For SHL Telemedicine (XSWX:SHLTN), the current Beneish M-Score is -3.22 as of Jun. 26, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is SHL Telemedicine (XSWX:SHLTN) Overvalued in 2026?

Based on GuruFocus' analysis, SHL Telemedicine stock appears to be undervalued. The current stock price of CHF0.91 is trading 65.3% below its estimated GF Value™ of CHF2.62. GuruFocus considers SHL Telemedicine to be Possible Value Trap.

Key valuation signals for XSWX:SHLTN:

  • Beneish M-Score: -3.22
  • GF Value™: CHF2.62 vs. price of CHF0.91 (65.3% below fair value)
  • GF Score™: 51/100 with 3 warning signs

No single metric tells the full story. See the XSWX:SHLTN stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.


SHL Telemedicine Business Description

Other Exchanges 0QMX:UK
Address 90 Yigal Alon Street, Tel Aviv, ISR, 67891
SHL Telemedicine Ltd develops and markets personal telemedicine solutions. The company consists of the transmission of medical data by an individual, from a remote location to a medical call center, through telecommunication networks. The company provides healthcare professional solutions to patients suffering from congestive heart failure, chronic obstructive pulmonary disease, and readmission solutions for reducing heart-related readmissions. In addition, consumer solutions include cardiac monitoring services. The company's geographical segments are Israel, Europe, and the rest of the world, out of which majority of revenue comes from Israel.
51GF Score

Get the complete analysis for XSWX:SHLTN

Beneish M-Score is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

CHF0.91
Price
CHF2.62
GF Value